Philips to Offer Integrated Image Guided Therapy Solutions in Canada
October 04 2016 - 7:00AM
Business Wire
Philips’ broad portfolio of imaging and measurement catheters
combined with its leading interventional imaging solutions provide
a comprehensive solution with the aim to enhance procedural
outcomes
Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has
incorporated its Volcano catheter-based imaging and measurement
solutions for minimally invasive diagnostics and treatment of
cardiovascular and other disease, into its robust portfolio of
interventional cardiology solutions in Canada.
“We are committed to delivering innovative solutions for our
customers in Canada and the patients they serve,” said Iain Burns,
President and CEO of Philips Canada. “The inclusion of our Volcano
products will provide our customers with better access to all of
the integrated technologies and specialized expertise across
Philips’ entire Image Guided Therapy portfolio. Offering our
customers these integrated solutions helps us achieve our goal of
equipping them with tools that can improve their patients’
care.”
Philips has an existing rich portfolio of interventional imaging
equipment, navigation tools and services, and a sizeable customer
base, including 85% of Canadian hospitals who have chosen Philips
cardiology solutions. Philips’ advanced interventional imaging
systems and navigation tools provide the visual maps that allow the
clinician to guide thin, tube-shaped instruments called catheters
through the body to the area of interest and perform the minimally
invasive treatment. In image-guided treatments of the heart and
blood vessels, there is increased clinical evidence which
demonstrates that the use of imaging and measurement catheters in
conjunction with interventional x-ray imaging helps improve
procedural outcomes.
Through its Volcano product portfolio, Philips is a world leader
in catheter-based imaging and measurements like IVUS (Intravascular
Ultrasound) catheters that are capable of producing ultrasound
images of the interior blood vessels and FFR/iFR (Fraction Flow
Reserve) technologies that are used to assess the blood pressure.
These solutions complement Philips’ portfolio of interventional
x-ray and ultrasound imaging equipment, navigation systems,
software and services; together they enable confident diagnosis and
treatment.
To learn more about Philips’ Image Guided Therapy solutions
click here or visit Philips Canada at the Canadian Cardiovascular
Congress in Montreal, Quebec from October 22nd to October 25th.
About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people’s health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health
informatics, as well as
in consumer health and home care. Philips’
health technology portfolio generated 2015 sales of EUR 16.8
billion and employs approximately 69,000 employees with sales and
services in more than 100 countries. News about Philips can be
found at www.philips.com/newscenter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161004005314/en/
Philips CanadaSantina Giuliano, 905-201-4196Communications
Managersantina.giuliano@philips.com
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From May 2023 to May 2024